Advance Search
YANG Bo, WANG Yanli, CUI Xiaojing. Value of combined detection of serum matrix metalloproteinase-9, soluble urokinase type plasmin activator receptor and plasmin activator inhibitor-1 in predicting prognosis of elderly patients with chronic heart failure[J]. Journal of Clinical Medicine in Practice, 2024, 28(3): 34-38. DOI: 10.7619/jcmp.20232709
Citation: YANG Bo, WANG Yanli, CUI Xiaojing. Value of combined detection of serum matrix metalloproteinase-9, soluble urokinase type plasmin activator receptor and plasmin activator inhibitor-1 in predicting prognosis of elderly patients with chronic heart failure[J]. Journal of Clinical Medicine in Practice, 2024, 28(3): 34-38. DOI: 10.7619/jcmp.20232709
shu

Value of combined detection of serum matrix metalloproteinase-9, soluble urokinase type plasmin activator receptor and plasmin activator inhibitor-1 in predicting prognosis of elderly patients with chronic heart failure

  • 1.

    Department of Cardiovascular Diseases, Langfang City Hospital of Traditional Chinese Medicine in Hebei Province, Langfang, Hebei, 065000

  • 2.

    Emergency Intensive Care Unit, Langfang City People's Hospital in Hebei Province, Langfang, Hebei, 065000

More Information
  • Received Date: August 27, 2023
  • Revised Date: November 27, 2023
  • Available Online: February 29, 2024
    Graphical Abstract
    • Abstract
  • Objective 

    To investigate the relationships of the expression of serum matrix metalloproteinase-9 (MMP-9), soluble urokinase type plasmin activator receptor (suPAR) and plasmin activator inhibitor-1 (PAI-1) with the cardiac function grading and prognosis in elderly patients with chronic heart failure (CHF).

    Methods 

    A total of 108 CHF patients and 50 healthy individuals with physical examination in the same period in Langfang City Hospital of Traditional Chinese Medicine were respectively selected as study group and control group. The blood samples were collected for detection of serum levels of MMP-9, suPAR and PAI-1. The differences in serum indicators among patients with different cardiac functional grades of the New York Heart Association (NYHA) and different prognoses were compared, and the predictive values of serum indicators for poor prognosis were analyzed as well.

    Results 

    Compared with the control group, the serum levels of MMP-9, suPAR and PAI-1 in the study group were significantly higher (P < 0.05). The levels of serum MMP-9, suPARand PAI-1 increased gradually and significantly in patients with the increase of NYHA grading as grade Ⅱ, grade Ⅲ and grade Ⅳ (P < 0.05). The results of the one-year follow-up showed that there were 65 cases with good prognosis and 43 cases with poor prognosis, and the poor prognosis rate was 39.81% (43/108). Compared with patients of good prognosis, patients with poor prognosis had higher age, higher incidence of complicated hypertension, lower left ventricular ejection fraction (LVEF), and higher levels of left ventricular end diastolic diameter (LVEDD), MMP-9, suPAR and PAI-1 (P < 0.05). Logistic regression analysis showed that age, MMP-9, suPAR and PAI-1 were the risk factors for poor prognosis in elderly patients with CHF, while LVEF was a protective factor for poor prognosis in elderly patients with CHF (P < 0.05). The area under the curve (AUC) of serum MMP-9, suPAR and PAI-1 detected separately and in combination were 0.711, 0.829, 0.768 and 0.840 respectively, the sensitivity and specificity of the three indexes in combination were 88.21% and 79.46% respectively.

    Conclusion 

    The expression levels of serum MMP-9, suPAR and PAI-1 in elderly patients with CHF are closely related to thecardiac functional grading and poor prognosis.

    • FullText(HTML)
    • References (16)
  • [1]
    徐佳慧, 胡世莲. 慢性心力衰竭的流行病学与预防措施[J]. 中国临床保健杂志, 2021, 24(6): 721-725. doi: 10.3969/J.issn.1672-6790.2021.06.001
    [2]
    徐筱璐, 徐翠荣, 路琰琰. 健康生态学视角下慢性心力衰竭患者预后效果评价指标的研究进展[J]. 中华现代护理杂志, 2020, 26(29): 4017-4021.
    [3]
    沈杰, 钟明, 罗永杰. 急性缺血性脑卒中患者血清基质金属蛋白酶-9、血管生成素1与神经功能缺损及近期预后的关系研究[J]. 实用医院临床杂志, 2021, 18(6): 95-99. https://www.cnki.com.cn/Article/CJFDTOTAL-YYLC202106027.htm
    [4]
    邹兰, 李国良, 严小新. 血浆中suPAR和D-二聚体水平与动脉粥样硬化性脑梗死患者斑块易损性相关研究[J]. 中国医药导报, 2019, 16(14): 47-50. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY201914014.htm
    [5]
    薛君, 张雅楠, 蔡志杰, 等. 血清纤溶酶原激活物抑制物-1水平与2型糖尿病合并超重或肥胖病人的血管并发症的相关性研究[J]. 内蒙古医科大学学报, 2019, 41(1): 42-46. https://www.cnki.com.cn/Article/CJFDTOTAL-NMYX201901010.htm
    [6]
    中华医学会心血管病学分会心力衰竭学组, 中国医师协会心力衰竭专业委员会, 中华心血管病杂志编辑委员会. 中国心力衰竭诊断和治疗指南2018[J]. 中华心血管病杂志, 2018, 46(10): 760-789. doi: 10.3760/cma.j.issn.0253-3758.2018.10.004
    [7]
    赵娟, 于晓硕, 于晓宇, 等. 血清MMP-2、MMP-9及NT-proBNP在慢性心力衰竭患者中的表达及相关性研究[J]. 现代中西医结合杂志, 2018, 27(35): 3941-3945. https://www.cnki.com.cn/Article/CJFDTOTAL-XDJH201835019.htm
    [8]
    BACKES Y, VAN DER SLUIJS K F, MACKIE D P, et al. Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic review[J]. Intensive Care Med, 2012, 38(9): 1418-1428. doi: 10.1007/s00134-012-2613-1
    [9]
    周明敏, 方帆, 许卫攀. 血清可溶性尿激酶型纤溶酶原激活物受体、红细胞分布宽度与老年慢性心力衰竭心功能及预后的关系[J]. 心脑血管病防治, 2022, 22(5): 30-33. https://www.cnki.com.cn/Article/CJFDTOTAL-XXFZ202205008.htm
    [10]
    陈玉, 杨柳, 李书平. 冠心病患者血清Lp-PLA2、suPAR、apoM水平与病变程度的相关性[J]. 贵阳医学院学报, 2021, 46(07): 851-856. https://www.cnki.com.cn/Article/CJFDTOTAL-GYYB202107018.htm
    [11]
    BORNÉ Y, PERSSON M, MELANDER O, et al. Increased plasma level of soluble urokinase plasminogen activator receptor is associated with incidence of heart failure but not atrial fibrillation[J]. Eur J Heart Fail, 2014, 16(4): 377-383. doi: 10.1002/ejhf.49
    [12]
    修春霞, 刘运秋, 刘晓宇. 血清suPAR、PAI-1对慢性阻塞性肺疾病合并支气管扩张的诊断价值[J]. 标记免疫分析与临床, 2022, 29(2): 309-315. https://www.cnki.com.cn/Article/CJFDTOTAL-BJMY202202026.htm
    [13]
    刘东霞, 王有余, 王茜, 等. PAI-1、miR-146a、AQP9在急性心肌梗死rt-PA静脉溶栓前后动态变化及与TIMI血流分级的关系[J]. 中国分子心脏病学杂志, 2022, 22(3): 4674-4681. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGFB202203008.htm
    [14]
    屈丽娜, 闫生玲. FABP、PAI-1、心肌纤维化指标在急性心肌梗死中的检测价值[J]. 南昌大学学报: 医学版, 2020, 60(4): 55-60. https://www.cnki.com.cn/Article/CJFDTOTAL-JXYB202004013.htm
    [15]
    赵茜, 董晓茜, 姜冲, 等. 老年慢性心力衰竭患者血清suPAR、PAI-1表达与预后的相关性研究[J]. 中国循证心血管医学杂志, 2022, 14(8): 936-939. https://www.cnki.com.cn/Article/CJFDTOTAL-PZXX202208009.htm
    [16]
    戴增欢, 郑伟珍, 阮发晖, 等. 血清suPAR水平与慢性心力衰竭患者预后的关系研究[J]. 中国循证心血管医学杂志, 2020, 12(2): 175-178. https://www.cnki.com.cn/Article/CJFDTOTAL-PZXX202002012.htm
    • Related Articles

  • Related Articles

    [1]SHAO Chunhui, JIANG Jue, ZHOU Qi, WANG Juan. Comparison of value of three methods alone and their combination in diagnosis of thyroid micronodules[J]. Journal of Clinical Medicine in Practice, 2024, 28(4): 19-24. DOI: 10.7619/jcmp.20232536
    [2]LIU Sen, ZHENG Yun. Value of combined application of ultrasound elastography, color Doppler blood flow imaging and contrast-enhanced ultrasound in differential diagnosis of breast occupying lesions[J]. Journal of Clinical Medicine in Practice, 2023, 27(24): 68-72. DOI: 10.7619/jcmp.20233092
    [3]SHAO Chunhui, WANG Juan, JIANG Jue, ZHOU Qi, LI Peiying, LUO Yongke. Value of strain elastography and shear wave elastography in the diagnosis of benign and malignant thyroid nodules[J]. Journal of Clinical Medicine in Practice, 2023, 27(19): 113-117. DOI: 10.7619/jcmp.20231977
    [4]WU Shiji, MUTAILIFU Nueraili, SHI Xuanfu, MA Ailin, WUBULIHASIMU Muhetajiang, LUO Baoming. Value of ultrasound risk stratification combined with BRAFV600E gene mutation detection in diagnosing category Ⅲ thyroid nodules in the Bethesda System for Reporting Thyroid Cytopathology[J]. Journal of Clinical Medicine in Practice, 2022, 26(19): 1-4. DOI: 10.7619/jcmp.20220996
    [5]LI Yuqin, FANG Yan, ZHANG Yan, ZHANG Suzhen, LIU Guanglan, DONG Hongwei. Diagnostic value of ultrasound assisted elastography combined with acoustic palpation tissue imaging quantification technique for superficial mass[J]. Journal of Clinical Medicine in Practice, 2022, 26(8): 13-16. DOI: 10.7619/jcmp.20214077
    [6]JIANG Yongling, HU Yu. Comparison of efficacy of Chinese-Thyroid Imaging Reporting and Data System and American Thyroid Association ultrasound model in diagnosis of thyroid nodule[J]. Journal of Clinical Medicine in Practice, 2022, 26(5): 6-9. DOI: 10.7619/jcmp.20214598
    [7]YANG Yajing, WANG Yunji, FENG Shangyong. Research progress of molecular detection in diagnosis of thyroid nodule[J]. Journal of Clinical Medicine in Practice, 2021, 25(2): 112-116, 121. DOI: 10.7619/jcmp.20201005
    [8]SHI Guorong, FANG Lili, SHEN Hongying, ZHI Fenyan. Diagnostic value of Thyroid Imaging Reporting and Data System combined with shear wave elastography in differentiating benign and malignant thyroid nodules[J]. Journal of Clinical Medicine in Practice, 2019, 23(22): 8-10. DOI: 10.7619/jcmp.201922003
    [9]ZHUANG Erbao, WANG Lei. Clinical significance of high frequency ultrasound combinedwith CT in diagnosis of thyroid papillary carcinoma[J]. Journal of Clinical Medicine in Practice, 2019, 23(18): 19-21. DOI: 10.7619/jcmp.201918006
    [10]LI Cuirong, YANG Jin, DING Xuefei. Value of transrectal ultrasound combined with imaging techniques in the diagnosis of benign and malignant prostate nodules[J]. Journal of Clinical Medicine in Practice, 2018, (9): 54-57. DOI: 10.7619/jcmp.201809014

  • Cited by

    Periodical cited type(8)

    1. 夏冬梅，石光顺，韩婷婷，金水. 血清半胱氨酸蛋白酶抑制剂S在胃癌患者中的诊断价值. 实用临床医药杂志. 2025(02): 48-51 . 本站查看
    2. 匡重英. 肿瘤标志物CEA、CA-199联合检测在消化道肿瘤诊断中的应用价值. 医学信息. 2025(03): 138-140+144 .
    3. 郑舒丹，杨柳. 内镜黏膜下剥离术与腹腔镜根治术用于早期结直肠癌患者临床疗效对比. 中国肿瘤外科杂志. 2025(01): 31-35 .
    4. 孙红梅. 胃肠镜检查联合血清CEA水平检测对消化道肿瘤早期诊断的价值分析. 中国实用医药. 2024(18): 88-90 .
    5. 陈阿红，周小安，花睿. 血清CRP与肿瘤标志物检测在消化道恶性肿瘤诊断中的价值. 检验医学与临床. 2022(11): 1502-1504+1509 .
    6. 周笑世，常江，彭立雄，柳溪林，尉发正，徐健峰，章沙沙，胡盼，柳增善，张国军. MC1R在食管鳞癌细胞和组织中高表达. 南方医科大学学报. 2022(10): 1552-1559 .
    7. 王远飚，董坚，李慧，马继龙，张琪鹏，张锦平，陈艳. 影响Ⅱ、Ⅲ期结直肠癌术后复发或转移的临床因素分析. 中国肿瘤外科杂志. 2022(06): 545-549 .
    8. 张营，闫隔，冯新歌. 胃肠镜检查联合血清CEA水平对消化道肿瘤的诊断价值分析. 湖北民族大学学报(医学版). 2022(04): 40-43+47 .

    Other cited types(2)

Catalog

    Get Citation
    PDF
    XML
    Article views (128) PDF downloads (8) Cited by(10)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return